Bioalert Technologies company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

About Bioalert Technologies

Bioalert Technologies develops a medical device intended to detect bacterial infections in real-time. The company's device is dedicated to the design and development of continuous infection monitoring systems for diabetic foot ulcer patients, enabling healthcare providers to make diagnosis and treatment decisions based on data metrics. It is based in Philadelphia, Pennsylvania.

Bioalert Technologies Headquarter Location

220 S 33rd St

Philadelphia, Pennsylvania, 19104,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Bioalert Technologies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Bioalert Technologies is included in 1 Expert Collection, including Diabetes.



1,750 items

  • Where is Bioalert Technologies's headquarters?

    Bioalert Technologies's headquarters is located at 220 S 33rd St, Philadelphia.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.